| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Janux Therapeutics Inc. Common Stock (NASDAQ: JANX)
JANX Technical Analysis
4
| As on 9th Jun 2023 JANX STOCK Price closed @ 12.58 and we RECOMMEND Sell for LONG-TERM with Stoploss of 14.46 & Strong Sell for SHORT-TERM with Stoploss of 17.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JANXSTOCK Price
| Open | 13.32 | Change | Price | % |
| High | 13.55 | 1 Day | -0.65 | -4.91 |
| Low | 12.34 | 1 Week | 1.20 | 10.54 |
| Close | 12.58 | 1 Month | -2.22 | -15.00 |
| Volume | 78489 | 1 Year | -7.44 | -37.16 |
| 52 Week High 22.21 | 52 Week Low 9.52 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| JANX Daily Charts |
JANX Intraday Charts |
Whats New @ Bazaartrend |
JANX Free Analysis |
|
|
JANX Important Levels Intraday
| RESISTANCE | 14.91 |
| RESISTANCE | 14.16 |
| RESISTANCE | 13.70 |
| RESISTANCE | 13.24 |
| SUPPORT | 11.92 |
| SUPPORT | 11.46 |
| SUPPORT | 11.00 |
| SUPPORT | 10.25 |
JANX Forecast May 2024
| 4th UP Forecast | 26.86 |
| 3rd UP Forecast | 22.28 |
| 2nd UP Forecast | 19.45 |
| 1st UP Forecast | 16.62 |
| 1st DOWN Forecast | 8.54 |
| 2nd DOWN Forecast | 5.71 |
| 3rd DOWN Forecast | 2.88 |
| 4th DOWN Forecast | -1.7 |
JANX Weekly Forecast
| 4th UP Forecast | 20.31 |
| 3rd UP Forecast | 17.83 |
| 2nd UP Forecast | 16.30 |
| 1st UP Forecast | 14.77 |
| 1st DOWN Forecast | 10.39 |
| 2nd DOWN Forecast | 8.86 |
| 3rd DOWN Forecast | 7.33 |
| 4th DOWN Forecast | 4.85 |
JANX Forecast2024
| 4th UP Forecast | 40.04 |
| 3rd UP Forecast | 31.23 |
| 2nd UP Forecast | 25.79 |
| 1st UP Forecast | 20.35 |
| 1st DOWN Forecast | 4.81 |
| 2nd DOWN Forecast | -0.63 |
| 3rd DOWN Forecast | -6.07 |
| 4th DOWN Forecast | -14.88 |
Janux Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : JANX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JANX Business Profile
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. It is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. The company was incorporated in 2017 and is headquartered in La Jolla, California. Address: 11099 North Torrey Pines Road, La Jolla, CA, United States, 92037
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service